Skip to main content

Lipe & Dalton

SEC CIK
0001570396
Latest filing
Jul 14, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Lipe & Dalton, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
3,761
Value
$1.87M
% of portfolio
0.9%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Lipe & Dalton, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,761$1.87M0.9%−235−5.9%ReducedHolders
Q1 20263,996$1.78M0.9%00.0%UnchangedHolders
Q4 20253,996$1.81M0.9%−250−5.9%ReducedHolders
Q3 20254,246$1.66M0.8%−60−1.4%ReducedHolders
Q2 20254,306$1.92M1.0%−275−6.0%ReducedHolders
Q1 20254,581$2.22M1.2%−400−8.0%ReducedHolders
Q4 20244,981$2.01M1.1%−10−0.2%ReducedHolders
Q3 20244,991$2.32M1.2%−50−1.0%ReducedHolders
Q2 20245,041$2.36M1.3%−94−1.8%ReducedHolders
Q1 20245,135$2.15M1.1%00.0%UnchangedHolders
Q4 20235,135$2.09M1.1%+100+2.0%AddedHolders
Q3 20235,035$1.75M1.1%00.0%UnchangedHolders
Q2 20235,035$1.77M1.0%−50−1.0%ReducedHolders
Q1 20235,085$1.60M0.9%−100−1.9%ReducedHolders
Q4 20225,185$1.50M0.9%−50−1.0%ReducedHolders
Q3 20225,235$1.52M1.0%−10−0.2%ReducedHolders
Q2 20225,245$1.48M0.9%+400+8.3%AddedHolders
Q1 20224,845$1.26M0.6%+650+15.5%AddedHolders
Q4 20214,195$921.0K0.4%00.0%UnchangedHolders
Q3 20214,195$761.0K0.4%−205−4.7%ReducedHolders
Q2 20214,400$887.0K0.5%+245+5.9%AddedHolders
Q1 20214,155$893.0K0.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.